Mosquito Allergy and Skeeter Syndrome: No US Immunotherapy, But Real Clinical Guidance
There is no FDA-approved mosquito immunotherapy in the US — the dominant clinical fact for any patient researching mosquito allergy shots. The majority of 'mosquito allergy' presentations are Skeeter syndrome, a large local inflammatory reaction with fever that is frequently misdiagnosed as bacterial cellulitis (Simons and Peng 1999 JACI 104:705). True mosquito anaphylaxis is rare.
Mosquito Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to mosquito — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of mosquito allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of mosquito immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of mosquito extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for mosquito allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing mosquito extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription mosquito immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat mosquito allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Mosquito?
The biology, taxonomy, and clinical fingerprint of Mosquito — the foundation of how SCIT targets it.
Aedes aegypti female mosquito — introduces saliva containing anticoagulants, vasodilators, and immunomodulators during blood feeding; reactions are to salivary proteins, not venom.
- Scientific name
- Aedes aegypti (also Aedes albopictus, Aedes vexans, Culex quinquefasciatus, Anopheles spp.)
- Family
- CulicidaeMosquito family
- Type
- Insect saliva (Order Diptera — NOT Hymenoptera; reaction is to salivary proteins, NOT venom; ~5 μL of saliva per bite)
- Native to
- Worldwide; all 50 US states; Aedes aegypti and A. albopictus established as far north as DC, NJ, and KS
- Allergen proteins
- Aed a 1 — Apyrase anticoagulant (68 kDa; major; Peng 1998 JACI 101:498)Aed a 2 — D7 protein (37 kDa; major)Aed a 3 — Salivary protein (30 kDa; major)Aed a 7 — D7-related protein (30 kDa; major)Aed a 10 — Tropomyosin (33 kDa; minor; cross-reactive with shellfish and dust-mite tropomyosin)
- Particle size
- N/A (salivary proteins, not pollen)
- Avoidance difficulty
- Very difficult
How Mosquito Allergy Presents
Symptoms by body system — useful for distinguishing Mosquito sensitivity from overlapping allergies and infections.
Local / Dermal (Skeeter Syndrome — the most common presentation)
- Large local swelling >10 cm around bite site, peaking 24–48 hours after bite
- Warm, indurated, erythematous plaque frequently misdiagnosed as cellulitis
- Fever and lymphangitis in severe Skeeter syndrome cases
- Pruritis and discomfort at bite site
- Resolution over days to 2 weeks without antibiotic treatment
Systemic (True Anaphylaxis — rare)
- Generalized urticaria and flushing beyond the bite site (distinguishes systemic from Skeeter syndrome)
- Throat tightness and difficulty breathing (rare, requires epinephrine + 911)
- Hypotension in severe anaphylaxis
- Loss of consciousness in the most severe documented cases
Respiratory (in true systemic reaction only)
- Bronchospasm and wheezing (uncommon, in true anaphylaxis only)
- Laryngeal edema (rare)
- Upper airway compromise requiring urgent epinephrine
Ocular
- Periorbital swelling from bite near the eye (common local reaction, not systemic)
- Conjunctival injection and tearing
- Eyelid edema
Most patients who come in with 'mosquito allergy' actually have Skeeter syndrome — a large local inflammatory reaction with fever and sometimes lymphangitis that gets misdiagnosed as cellulitis and treated with unnecessary antibiotics. True mosquito anaphylaxis is rare. There is no FDA-approved mosquito immunotherapy in the US, so management is repellent, permethrin-treated clothing, antihistamines, and topical steroids — and most importantly, distinguishing Skeeter syndrome from bacterial infection.
When & Where Mosquito Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: June through August in northern US; year-round activity in southern US (FL, TX, LA) and coastal California· ~5 months of peak exposure in most of the US; year-round in warm-weather states
US Exposure Map
9 high-intensity statesWhat Mosquito Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Mosquito allergens have limited but documented cross-reactivity with other arthropods via pan-allergen tropomyosin (Aed a 10), though this cross-reactivity is typically clinically silent rather than a driver of clinical allergic reactions.
Aed a 10 tropomyosin ↔ Bla g 7 / Per a 7 cockroach tropomyosin — pan-arthropod tropomyosin cross-reactivity; limited clinical relevance (Cantillo 2014 Int Arch Allergy Immunol 165:271)
Aed a 10 tropomyosin ↔ Der p 10 dust-mite tropomyosin — minor cross-reactivity (Peng 1997 JACI 100:192)
Is SCIT Right for Your Mosquito Allergy?
Answer 5 questions to understand your mosquito bite reaction type and the management options available to you.
Which best describes your typical mosquito bite reaction?
The Mosquito SCIT Protocol
There is no FDA-approved mosquito immunotherapy in the US — management is entirely avoidance-based and symptom-oriented. Limited European experimental data with salivary-gland extract remains investigational and is not a clinical option for US patients.
CDC-recommended insect repellents: DEET 20–30% (most evidence), picaridin 20%, IR3535, or oil of lemon eucalyptus (OLE) for adults. Permethrin-treated clothing, long sleeves, and long pants reduce bite incidence substantially. Environmental measures — eliminating standing water in containers, gutters, tire ruts, bird baths — reduce local mosquito populations. Window and door screens plus bed nets in high-burden areas.
Skeeter syndrome: oral non-sedating H1 antihistamines (cetirizine 10 mg or fexofenadine 180 mg), topical corticosteroid (low-potency hydrocortisone to mid-potency triamcinolone), cool compresses. Antibiotics are NOT indicated for Skeeter syndrome unless secondary infection confirmed (purulent drainage, expanding erythema beyond the reaction border after 48–72 h, fever, systemic signs). True anaphylaxis: epinephrine auto-injector + 911 + ED transport immediately.
Limited European experimental SIT data with salivary-gland extract (Ariano 2009; McCormack 1995) suggested modest reduction in immediate skin-test reactivity but limited clinical translation. This approach is investigational, not FDA-approved, and not a clinical option for US patients in 2026. Patients seeking SIT for mosquito allergy should be counseled that this is not a standard-of-care option in the US.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Mosquito SCIT
There is no FDA-approved mosquito immunotherapy in the US with demonstrated clinical efficacy; the available evidence is limited to European investigational salivary-gland extract SIT with modest and inconsistent results.
- Reduction in skin-test reactivity with experimental SIT (European data only)30%Ariano 2009; McCormack 1995 — modest reduction in immediate skin-test reactivity, limited clinical translation
- Skeeter syndrome prevalence in sensitized individuals (not immunotherapy outcome)45%Simons and Peng 1999, JACI 104:705 — Skeeter syndrome predominantly affects young children and immunocompromised individuals
No FDA-approved mosquito immunotherapy exists in the US with demonstrated clinical efficacy for reducing systemic reaction risk. Avoidance, repellents, and symptomatic management remain the evidence-based standard of care. European experimental SIT data is not sufficient to support use as standard therapy per AAAAI practice parameters.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Mosquito SCIT Side Effects
Since no FDA-approved mosquito immunotherapy exists in the US, this section covers the risk distinction between Skeeter syndrome and secondary infection — the most clinically important side-effect analog for mosquito bite reactions.
Local reactions
3 documentedSystemic reactions
2 documentedSkeeter syndrome is an IgE-mediated large local inflammatory reaction that does NOT represent bacterial cellulitis and does NOT require systemic antibiotics. This distinction prevents unnecessary antibiotic prescribing, which occurs frequently (Simons and Peng 1999 JACI 104:705). If true infection is suspected (purulent drainage, worsening erythema >72 h, fever, lymphangitis extending from the bite site), consult a physician.
SCIT vs Alternatives for Mosquito
There is no curative immunotherapy for mosquito allergy in the US. Management alternatives are avoidance strategies, symptomatic pharmacotherapy, and — for the rare true anaphylaxis patient — epinephrine auto-injectors.
| Criterion | Repellent + ClothingBest | Oral Antihistamines | Topical Corticosteroids | Investigational SIT |
|---|---|---|---|---|
| Effectiveness | Highly effective when used consistently (DEET 20–30%, picaridin 20%) | Reduces Skeeter syndrome severity; does not prevent systemic anaphylaxis | Reduces local inflammation and pruritis of Skeeter syndrome | Not FDA-approved; modest and inconsistent European data |
| Cost | Low — $20–$50/season | Low — <$50/year OTC | Low — OTC hydrocortisone or Rx mid-potency | Not available in US |
| Duration | Seasonal/ongoing | Daily during exposure season | Per episode | N/A in US |
| Convenience | Apply before each outdoor exposure | Oral, convenient; non-sedating preferred (cetirizine, fexofenadine) | Apply to bite site; not for broken skin | Not clinically available in US |
| Safety | Safe; DEET safe for children >2 months per AAP | Safe; sedation with 1st-gen antihistamines | Safe at low potency; skin thinning with chronic use of high potency | Unknown in real-world settings |
| Lasting effect | No immunologic effect; prevents exposure only | No lasting effect on sensitization | Symptomatic only; no desensitization | Not established |
Repellent + ClothingBest
Oral Antihistamines
Topical Corticosteroids
Investigational SIT
Consistent use of EPA-registered repellents (DEET 20–30% or picaridin 20%) plus permethrin-treated clothing is the most evidence-based protection strategy for mosquito allergy patients. For patients who also have inhalant allergies — dust mite, cat, dog, or grass — which commonly coexist in outdoor-exposure individuals, Curex addresses those concurrent aeroallergens with at-home allergy shots at $129/month, prescribed and overseen by a board-certified allergist with the first dose and every dose change supervised live over video and a prescribed epinephrine auto-injector confirmed on hand. That at-home aeroallergen plan addresses a separate symptom burden alongside mosquito avoidance.
What Mosquito SCIT Actually Costs
Mosquito-specific IgE testing (when available through specialized labs) may be covered under standard laboratory benefits. Allergist consultation for Skeeter syndrome diagnosis and epinephrine prescription is covered under standard allergy benefits. No mosquito immunotherapy is billable because no FDA-licensed product exists. Curex at-home IgE testing identifies specific mosquito sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your mosquito allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Mosquito SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Skeeter syndrome is the term for mosquito-bite–induced large local inflammatory reactions with fever, sometimes accompanied by lymphangitis (Simons and Peng 1999 JACI 104:705). It is an IgE-mediated hypersensitivity reaction to mosquito salivary proteins and is NOT a bacterial infection — the hallmark confusion in clinical practice. Skeeter syndrome presents as a warm, erythematous, indurated plaque >10 cm around the bite site, developing within hours of the bite and peaking at 24–48 hours. Crucially, it resolves over days to 2 weeks without antibiotic treatment. Antibiotics are not indicated for Skeeter syndrome unless secondary bacterial superinfection is confirmed by purulent drainage, worsening erythema after 48–72 hours, or systemic fever. Skeeter syndrome predominantly affects young children and immunocompromised individuals who have not developed immunologic tolerance to mosquito saliva.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.